Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
Milestone Scientific, Inc. (MLSS)
NASDAQ:AMEX Investor Relations:
ir.milestonescientific.com
Company Research
Source: GlobeNewswire
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals’ retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more time with his family and pursue other personal interests. His decision to step down was not the result of any disagreement with Milestone Scientific’s Board of Directors or management. As part of the transition, Neal Goldman, Chairman of the Board, has been appointed as Interim CEO, effective upo
Show less
Read more
Impact Snapshot
Event Time:
MLSS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLSS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLSS alerts
High impacting Milestone Scientific, Inc. news events
Weekly update
A roundup of the hottest topics
MLSS
News
- Milestone Scientific Inc. (NYSE: MLSS) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $1.25 price target on the stock.MarketBeat
- Milestone Scientific Inc. (NYSE: MLSS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]Yahoo! Finance
- Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 [Yahoo! Finance]Yahoo! Finance
MLSS
Sec Filings
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- 10/23/24 - Form 4
- MLSS's page on the SEC website